Neovasculature, Plaque Rupture And Progression by MRI
Neovasculature, Plaque Rupture And Progression by MRI
批准号:
7105580
负责人:
THOMAS HATSUKAMI
金额:
$49.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
amyloid proteinsangiogenesisatherosclerosisatherosclerotic plaquecardiovascular disorder diagnosiscardiovascular disorder riskcarotid arteryclinical researchdiagnosis design /evaluationdisease /disorder classificationendarterectomyhistopathologyhuman subjectlongitudinal human studymacrophagemagnetic resonance imagingmetalloendopeptidasesmethod developmentpathologic processpostmortemprognosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal of Project 2 is to use high-resolution magnetic resonance imaging (MRI) to study
mechanisms that may be involved in the progression of carotid atherosclerosis from a sub-clinical lesion to a high-risk plaque. Specifically, we will examine the relationships between neovasculature in the diseased carotid artery, fibrous cap status, and plaque burden. Histological studies suggest that the high-risk plaque is characterized by thinning and rupture of the fibrous cap that ovedies the thrombogenic necrotic core, which in turn may lead to thrombotic occlusion of the vessel or embolization of material downstream. Furthermore, cap rupture with overlying mural thrombus formation may lead to an increase in overall plaque
volume. Other studies suggest an important role for plaque neovasculature. Neovessels within plaque are believed to represent a pathway for macrophage infiltration, and these macrophages have been shown to express matrix metalloproteinases that can weaken the fibrous cap.
With funding from the NIH, we have shown that MRI is capable of precisely measuring plaque volume, distinguish thick fibrous caps from thin and ruptured caps, and identify regions with plaque neovasculature. We plan to serially examine 275 subjects with early, subclinical carotid atherosclerosis with pre-and postcontrast enhanced MRI. The specific aims of this study are to test three hypotheses regarding mechanisms of progression to a high-dsk]esion: 1. that fibrous cap thinning and rupture precedes increase in plaque burden; 2. that increased neovasculature in the diseased carotid artery, as identified by MRI, predicts a higher risk for progression in plaque burden; and 3. that plaques with increased neovasculature are more likely progress from a thick cap to a thin or ruptured cap lesion. A better understanding of the mechanisms
leading to the development of the high-risk plaque may provide new targets for therapy. Furthermore, identification of additional high-risk plaque features, other than the degree of lumen stenosis, may lead to better selection of patients for intervention, such as carotid endarterectomy, and result in overall reduction in health care costs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Culprit Plaque in Acute Cerebral Infarction: A Histological and MRI Assessment
-
批准号:8720084
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2013
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Culprit Plaque in Acute Cerebral Infarction: A Histological and MRI Assessment
-
批准号:8883737
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Culprit Plaque in Acute Cerebral Infarction: A Histological and MRI Assessment
-
批准号:8547553
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Carotid Intraplaque Hemorrhage: MRI of Therapeutic Response and Clinical Sequelae
-
批准号:9308585
-
项目类别:
-
资助金额:$82.29万
-
财政年份:2011
-
负责人:THOMAS HATSUKAMI
-
依托单位:
PET/MRI of atherosclerosis
-
批准号:8028896
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2011
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Carotid Intraplaque Hemorrhage: MRI of Therapeutic Response and Clinical Sequelae
-
批准号:10092205
-
项目类别:
-
资助金额:$71.69万
-
财政年份:2011
-
负责人:THOMAS HATSUKAMI
-
依托单位:
PET/MRI of atherosclerosis
-
批准号:8259719
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2011
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Magnetic Resonance Imaging of Vulnerable Plaque
-
批准号:6602315
-
项目类别:
-
资助金额:$57.06万
-
财政年份:2003
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Magnetic Resonance Imaging of Vulnerable Plaque
-
批准号:6748090
-
项目类别:
-
资助金额:$58.26万
-
财政年份:2003
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Magnetic Resonance Imaging of Vulnerable Plaque
-
批准号:7062485
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2003
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Magnetic Resonance Imaging of Vulnerable Plaque
-
批准号:6894648
-
项目类别:
-
资助金额:$59.73万
-
财政年份:2003
-
负责人:THOMAS HATSUKAMI
-
依托单位:
Neovasculature, Plaque Rupture And Progression by MRI
-
批准号:6678749
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2002
-
负责人:THOMAS HATSUKAMI
-
依托单位:
MRI IDENTIFICATION OF FIBROUS CAP ATROPHY AND RUPTURE
-
批准号:6185095
-
项目类别:
-
资助金额:$29.25万
-
财政年份:1998
-
负责人:THOMAS HATSUKAMI
-
依托单位:
MRI IDENTIFICATION OF FIBROUS CAP ATROPHY AND RUPTURE
-
批准号:2752405
-
项目类别:
-
资助金额:$29.09万
-
财政年份:1998
-
负责人:THOMAS HATSUKAMI
-
依托单位:
MRI IDENTIFICATION OF FIBROUS CAP ATROPHY AND RUPTURE
-
批准号:6390190
-
项目类别:
-
资助金额:$29.25万
-
财政年份:1998
-
负责人:THOMAS HATSUKAMI
-
依托单位:
MRI IDENTIFICATION OF FIBROUS CAP ATROPHY AND RUPTURE
-
批准号:6078057
-
项目类别:
-
资助金额:$29.25万
-
财政年份:1998
-
负责人:THOMAS HATSUKAMI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: